相关实验视频

Updated: Jun 22, 2025

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

循环瘤细胞:在小细胞肺癌患者中推进个性化治疗

Prajwol Shrestha^1,2,3, Steven Kao^4,5, Veronica K Cheung^4,6

¹Li Ka Shing Cell and Gene Therapy Program, Faculty of Medicine and Health, University of Sydney, Camperdown, Australia.

Molecular oncology

|July 3, 2024

概括

小细胞肺癌 (SCLC) 的生存率很低. 新型向疗法和循环瘤细胞 (CTC) 显示出对精准医学的前景,但CTC却是有前途的.

科学领域:

在瘤学瘤学.
翻译医学是一种翻译医学.
分子诊断学分子诊断

背景情况:

尽管目前的治疗方法,小细胞肺癌 (SCLC) 具有攻击性,存活率低 (在5年内<7%).
像三角形状联体3 (DLL3) 和 schlafen11 (SLFN11) 这样的生物标志物对于向疗法至关重要.
在SCLC的组织活检挑战需要替代的诊断方法.

研究的目的:

审查针对SCLC的新型向疗法.
总结目前对SCLC中循环瘤细胞 (CTC) 的理解.
探索CTCs在SCLC指导精准医学中的实用性.

主要方法:

在SCLC中针对性治疗的文献综述.
关于SCLC中循环瘤细胞 (CTC) 的现有研究概述.
讨论CTC在SCLC精密医学中的潜在应用.

主要成果:

新型向治疗,包括双特异性抗体 (tarlatamab) 和PARP抑制剂,显示出潜在的潜力.
循环瘤细胞 (CTC) 提供了一种微侵袭的分子分析方法.
虽然CTC具有预后价值,但它们在指导SCLC治疗决策中的作用需要进一步调查.

结论:

以DLL3和SLFN11等生物标志物为指导的向疗法代表了SCLC治疗的有希望的途径.
循环瘤细胞 (CTC) 对SCLC的非侵入性分子表征具有显著的潜力.
需要进一步的研究来确定CTC作为SCLC个性化治疗选择的可靠工具.

关键词:

在 DLL3 中,你会看到 DLL3 文件.液体活检活检液体活检斯克莱芬11 时间有针对性的治疗方法.塔拉塔塔马巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴胸部瘤学胸部瘤学

更多相关视频

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

Published on: December 25, 2021

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.